efaproxiral

DRUG5 trials

Sponsors

Spectrum Pharmaceuticals, Inc, New Approaches to Brain Tumor Therapy Consortium

Conditions

Brain and Central Nervous System TumorsBreast CancerLung CancerMetastasesMetastatic Cancer

Phase 1

Efaproxiral Plus Carmustine in Treating Patients With Progressive or Recurrent Malignant Glioma

CompletedNCT00005855

New Approaches to Brain Tumor Therapy ConsortiumBrain and Central Nervous System Tumors

Start: 2000-07-31End: 2006-10-31Target: 48Updated: 2013-06-21

Phase 2

Combination Chemotherapy, Radiation Therapy, and RSR13 in Treating Patients With Stage III Non-small Cell Lung Cancer

CompletedNCT00004202

Spectrum Pharmaceuticals, IncLung Cancer

Start: 1998-10-31End: 2003-01-31Updated: 2021-08-26

Phase 3

Chemotherapy and Radiation Therapy With or Without Efaproxiral in Treating Patients With Stage III Non-Small Cell Lung Cancer

WithdrawnNCT00055887

Spectrum Pharmaceuticals, IncLung Cancer

Start: 2002-11-30Updated: 2013-05-10

Radiation Therapy With or Without RSR13 in Treating Patients With Brain Metastases

CompletedNCT00005887

Spectrum Pharmaceuticals, IncMetastatic Cancer

Start: 2000-02-29End: 2003-01-31Updated: 2021-08-23

Whole Brain Radiation Therapy With Oxygen, With or Without RSR13, in Women With Brain Metastases From Breast Cancer

CompletedNCT00083304

Spectrum Pharmaceuticals, IncBreast Cancer, Metastases

Start: 2004-02-29End: 2007-06-30Updated: 2013-05-10